The change in the handbook, which could have significant financial
implications for the $10 billion U.S. antidepressant market, was
developed in large part by people affiliated with the pharmaceutical
industry, an examination of financial disclosures shows.
http://tinyurl.com/ctrp4hh (WaPo)
Powered by LSoft's LISTSERV(R) list management software